Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

High-Grade Gliomas in Children with Neurofibromatosis Type 1: Literature Review and Illustrative Cases.

Spyris CD, Castellino RC, Schniederjan MJ, Kadom N.

AJNR Am J Neuroradiol. 2019 Feb;40(2):366-369. doi: 10.3174/ajnr.A5888. Epub 2018 Dec 20.

PMID:
30573459
2.

Intracranial visual pathway gliomas in children with neurofibromatosis.

Packer RJ, Bilaniuk LT, Cohen BH, Braffman BH, Obringer AC, Zimmerman RA, Siegel KR, Sutton LN, Savino PJ, Zackai EH, et al.

Neurofibromatosis. 1988;1(4):212-22.

PMID:
3152473
3.

Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.

Byrne S, Connor S, Lascelles K, Siddiqui A, Hargrave D, Ferner RE.

J Neurooncol. 2017 Jul;133(3):609-614. doi: 10.1007/s11060-017-2475-z. Epub 2017 Jun 7.

4.

Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.

Abrigo JM, Fountain DM, Provenzale JM, Law EK, Kwong JS, Hart MG, Tam WWS.

Cochrane Database Syst Rev. 2018 Jan 22;1:CD011551. doi: 10.1002/14651858.CD011551.pub2. Review.

PMID:
29357120
5.

Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis.

Rozen WM, Joseph S, Lo PA.

Pediatr Neurosurg. 2008;44(4):324-8. doi: 10.1159/000134925. Epub 2008 May 27. Review.

PMID:
18504420
6.

Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas.

Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, Hoving EW, Meijer L, den Dunnen WF, de Bont ES.

Crit Rev Oncol Hematol. 2016 Aug;104:30-41. doi: 10.1016/j.critrevonc.2016.05.008. Epub 2016 May 21. Review.

7.

Radiation-induced gliomas in 2 pediatric patients with neurofibromatosis type 1: case study and summary of the literature.

Madden JR, Rush SZ, Stence N, Foreman NK, Liu AK.

J Pediatr Hematol Oncol. 2014 Mar;36(2):e105-8. doi: 10.1097/MPH.0000000000000006. Review.

PMID:
24136023
8.

Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions.

Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, Samnick S, Maasjosthusmann U, Lerch H, Gildehaus FJ, Wassmann H, Schober O.

Eur J Nucl Med. 1996 Oct;23(10):1345-53.

PMID:
8781139
9.

The role of 13N-ammonia in the differential diagnosis of gliomas and brain inflammatory lesions.

Yi C, Shi X, Zhang X, Luo G, Zhang B, Zhang X.

Ann Nucl Med. 2019 Jan;33(1):61-67. doi: 10.1007/s12149-018-1308-2. Epub 2018 Oct 22.

PMID:
30350180
10.

Adult anaplastic pilocytic astrocytoma - a diagnostic challenge? A case series and literature review.

Fiechter M, Hewer E, Knecht U, Wiest R, Beck J, Raabe A, Oertel MF.

Clin Neurol Neurosurg. 2016 Aug;147:98-104. doi: 10.1016/j.clineuro.2016.06.005. Epub 2016 Jun 6. Review.

11.

High-Grade Glioma is not a Feature of Neurofibromatosis Type 2 in the Unirradiated Patient.

King AT, Rutherford SA, Hammerbeck-Ward C, Lloyd SK, Freeman SM, Pathmanaban ON, Rodriguez-Valero M, Thomas OM, Laitt RD, Stivaros S, Kellett M, Evans DG.

Neurosurgery. 2018 Aug 1;83(2):193-196. doi: 10.1093/neuros/nyx374.

PMID:
28973691
12.

The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.

Solga AC, Toonen JA, Pan Y, Cimino PJ, Ma Y, Castillon GA, Gianino SM, Ellisman MH, Lee DY, Gutmann DH.

Oncotarget. 2017 Jul 18;8(29):47206-47215. doi: 10.18632/oncotarget.17589.

13.

Using R2* values to evaluate brain tumours on magnetic resonance imaging: preliminary results.

Liu Z, Liao H, Yin J, Li Y.

Eur Radiol. 2014 Mar;24(3):693-702. doi: 10.1007/s00330-013-3057-x. Epub 2013 Nov 26.

PMID:
24275803
14.

Optic pathway gliomas in children with and without neurofibromatosis 1.

Czyzyk E, Jóźwiak S, Roszkowski M, Schwartz RA.

J Child Neurol. 2003 Jul;18(7):471-8.

PMID:
12940652
15.

High- and low-grade glioma differentiation: the role of percentage signal recovery evaluation in MR dynamic susceptibility contrast imaging.

Aprile I, Giovannelli G, Fiaschini P, Muti M, Kouleridou A, Caputo N.

Radiol Med. 2015 Oct;120(10):967-74. doi: 10.1007/s11547-015-0511-7. Epub 2015 Mar 12.

PMID:
25762408
16.

Macrocephaly in neurofibromatosis type 1: a sign post for optic pathway gliomas?

Schindera C, Wingeier K, Goeggel Simonetti B, Diepold M, Nauer CB, Fleischhauer J, Steinlin M.

Childs Nerv Syst. 2011 Dec;27(12):2107-11. doi: 10.1007/s00381-011-1554-2. Epub 2011 Aug 7.

17.

IDH1 status is significantly different between high-grade thalamic and superficial gliomas.

Zuo M, Li M, Chen N, Yu T, Kong B, Liang R, Wang X, Mao Q, Liu Y.

Cancer Biomark. 2017 Aug 23;20(2):183-189. doi: 10.3233/CBM-170175.

PMID:
28869450
18.

Voxel-based clustered imaging by multiparameter diffusion tensor images for glioma grading.

Inano R, Oishi N, Kunieda T, Arakawa Y, Yamao Y, Shibata S, Kikuchi T, Fukuyama H, Miyamoto S.

Neuroimage Clin. 2014 Aug 7;5:396-407. doi: 10.1016/j.nicl.2014.08.001. eCollection 2014.

19.

Favorable prognosis for brainstem gliomas in neurofibromatosis.

Milstein JM, Geyer JR, Berger MS, Bleyer WA.

J Neurooncol. 1989 Nov;7(4):367-71.

PMID:
2511279
20.

Optic Pathway Gliomas Secondary to Neurofibromatosis Type 1.

Beres SJ, Avery RA.

Semin Pediatr Neurol. 2017 May;24(2):92-99. doi: 10.1016/j.spen.2017.04.006. Epub 2017 Apr 10. Review.

PMID:
28941532

Supplemental Content

Support Center